John W. Hadden

5.9k total citations
173 papers, 4.2k citations indexed

About

John W. Hadden is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, John W. Hadden has authored 173 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Immunology, 33 papers in Molecular Biology and 32 papers in Oncology. Recurrent topics in John W. Hadden's work include Immune Cell Function and Interaction (34 papers), Immunotherapy and Immune Responses (26 papers) and Immune Response and Inflammation (17 papers). John W. Hadden is often cited by papers focused on Immune Cell Function and Interaction (34 papers), Immunotherapy and Immune Responses (26 papers) and Immune Response and Inflammation (17 papers). John W. Hadden collaborates with scholars based in United States, Mexico and France. John W. Hadden's co-authors include Elba M. Hadden, Ronald G. Coffey, Elliott Middleton, Nelson D. Goldberg, Mari K. Haddox, Robert A. Good, John R. Sadlik, Edward M. Johnson, Geoffrey H. Sunshine and Emma Verástegui and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

John W. Hadden

172 papers receiving 3.7k citations

Peers

John W. Hadden
Charles Kunsch United States
Dolph O. Adams United States
Lois B. Epstein United States
Dennis E. Van Epps United States
John W. Hadden
Citations per year, relative to John W. Hadden John W. Hadden (= 1×) peers Yacob Weinstein

Countries citing papers authored by John W. Hadden

Since Specialization
Citations

This map shows the geographic impact of John W. Hadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Hadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Hadden more than expected).

Fields of papers citing papers by John W. Hadden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Hadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Hadden. The network helps show where John W. Hadden may publish in the future.

Co-authorship network of co-authors of John W. Hadden

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Hadden. A scholar is included among the top collaborators of John W. Hadden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Hadden. John W. Hadden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berinstein, Neil L., Gregory T. Wolf, Paul H. Naylor, et al.. (2011). Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen. Cancer Immunology Immunotherapy. 61(6). 771–782. 35 indexed citations
2.
Czystowska, Malgorzata, Mirosław J. Szczepański, Marta Szajnik, et al.. (2010). Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic. Cancer Immunology Immunotherapy. 60(4). 495–506. 19 indexed citations
3.
Naylor, Paul H., et al.. (2007). Immunopharmacology of Thymosin α1 and Cytokine Synergy. Annals of the New York Academy of Sciences. 1112(1). 235–244. 15 indexed citations
4.
Petrovický, P, et al.. (2003). Neuroendocrine immune interactions in health and disease. International Immunopharmacology. 3(8). 1235–1246. 48 indexed citations
5.
Masihi, K. Noel & John W. Hadden. (2002). Protection by methyl inosine monophosphate (MIMP) against aerosol influenza virus infection in mice. International Immunopharmacology. 2(6). 835–841. 5 indexed citations
6.
Dueñas‐González, Alfonso, Emma Verástegui, C. López‐Graniel, et al.. (2002). A pilot study of perilymphatic leukocyte cytokine mixture (IRX-2) as neoadjuvant treatment for early stage cervical carcinoma: preliminary report. International Immunopharmacology. 2(7). 1007–1016. 7 indexed citations
7.
Estrada‐Parra, Sergio, et al.. (2001). Immunomodulatory properties of Mycoplasma pulmonis. International Immunopharmacology. 1(9-10). 1679–1688. 10 indexed citations
8.
Hadden, John W.. (1998). Thymic Endocrinology. Annals of the New York Academy of Sciences. 840(1). 352–358. 41 indexed citations
9.
Hadden, John W., et al.. (1995). Immunotherapy with natural interleukins and/or thymosin α1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice. International Journal of Immunopharmacology. 17(10). 821–828. 24 indexed citations
10.
Hadden, Elba M., et al.. (1995). Methyl inosine monophosphate (MIMP) augments T-lymphocyte mitogen responses and reverses various immunosuppressants. International Journal of Immunopharmacology. 17(9). 763–770. 4 indexed citations
11.
Sauro, Marie D. & John W. Hadden. (1995). Cell-Free Thymic Extract from Hypertensive Rats Induces Hypertension in Normotensive Rats. Immunopharmacology and Immunotoxicology. 17(1). 137–149. 1 indexed citations
12.
Hadden, John W., et al.. (1994). Interleukins and Contrasuppression Induce Immune Regression of Head and Neck Cancer. Archives of Otolaryngology - Head and Neck Surgery. 120(4). 395–403. 55 indexed citations
13.
Hadden, John W.. (1993). Immunostimulants. Immunology Today. 14(6). 275–280. 49 indexed citations
14.
Sauro, Marie D. & John W. Hadden. (1992). Gamma-interferon corrects aberrant protein kinase C levels and immunosuppression in the spontaneously hypertensive rat. International Journal of Immunopharmacology. 14(8). 1421–1427. 9 indexed citations
15.
Hadden, John W.. (1990). Immunopharmacologic Aspects of Lipopolysaccharide Endotoxin Action with Special Reference to Cyclic Nucleotides. Advances in experimental medicine and biology. 256. 375–387. 4 indexed citations
16.
Hadden, John W.. (1988). Transmembrane signals in the activation of T-lymphocytes by lectin mitogens. Molecular Immunology. 25(11). 1105–1112. 37 indexed citations
17.
Hadden, John W. & Ronald G. Coffey. (1980). Effects of BM 12,531 (Azimexon) on in Vitro Lymphocyte and Macrophage Proliferation. Recent results in cancer research. 75. 162–164. 3 indexed citations
18.
Sunshine, Geoffrey H., et al.. (1978). Thymopoietin Enhances the Allogeneic Response and Cyclic GMP Levels of Mouse Peripheral, Thymus-Derived Lymphocytes. The Journal of Immunology. 120(5). 1594–1599. 73 indexed citations
19.
Touraine, J.L., John W. Hadden, F. Touraine, et al.. (1977). Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation.. The Journal of Experimental Medicine. 145(2). 460–465. 169 indexed citations
20.
Leu, Richard W., A L Eddleston, John W. Hadden, & Robert A. Good. (1972). MECHANISM OF ACTION OF MIGRATION INHIBITORY FACTOR (MIF). The Journal of Experimental Medicine. 136(3). 589–603. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026